{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:55:36Z","timestamp":1778882136407,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia","award":["11-MED-2086-02"],"award-info":[{"award-number":["11-MED-2086-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3747-x","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T04:32:31Z","timestamp":1510201951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing"],"prefix":"10.1186","volume":"17","author":[{"given":"Soundararajan","family":"Krishnaswamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Khader","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyanendra","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed S.","family":"Alokail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser M.","family":"Al-Daghri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"issue":"6","key":"3747_CR1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/cncr.22490","volume":"109","author":"ER Camp","year":"2007","unstructured":"Camp ER, Yang A, Gray MJ, Fan F, Hamilton SR, Evans DB, Hooper AT, Pereira DS, Hicklin DJ, Ellis LM. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. Cancer. 2007;109(6):1030\u20139.","journal-title":"Cancer"},{"issue":"8","key":"3747_CR2","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/carcin\/21.8.1507","volume":"21","author":"MH Wang","year":"2000","unstructured":"Wang MH, Kurtz AL, Chen Y. Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells. Carcinogenesis. 2000;21(8):1507\u201312.","journal-title":"Carcinogenesis"},{"issue":"9","key":"3747_CR3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/138945010792006825","volume":"11","author":"KL Kretschmann","year":"2010","unstructured":"Kretschmann KL, Eyob H, Buys SS, Welm AL. The macrophage stimulating protein\/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression. Curr Drug Targets. 2010;11(9):1157\u201368.","journal-title":"Curr Drug Targets"},{"issue":"22","key":"3747_CR4","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/sj.onc.1201812","volume":"16","author":"P Maggiora","year":"1998","unstructured":"Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P, Comoglio PM. Overexpression of the RON gene in human breast carcinoma. Oncogene. 1998;16(22):2927\u201333.","journal-title":"Oncogene"},{"issue":"12","key":"3747_CR5","first-page":"2627","volume":"11","author":"G Gaudino","year":"1995","unstructured":"Gaudino G, Avantaggiato V, Follenzi A, Acampora D, Simeone A, Comoglio PM. The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene. 1995;11(12):2627\u201337.","journal-title":"Oncogene"},{"issue":"4","key":"3747_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1172\/JCI119214","volume":"99","author":"O Sakamoto","year":"1997","unstructured":"Sakamoto O, Iwama A, Amitani R, Takehara T, Yamaguchi N, Yamamoto T, Masuyama K, Yamanaka T, Ando M, Suda T. Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility. J Clin Invest. 1997;99(4):701\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"3747_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/excr.1996.0200","volume":"226","author":"MH Wang","year":"1996","unstructured":"Wang MH, Dlugosz AA, Sun Y, Suda T, Skeel A, Leonard EJ. Macrophage-stimulating protein induces proliferation and migration of murine keratinocytes. Exp Cell Res. 1996;226(1):39\u201346.","journal-title":"Exp Cell Res"},{"key":"3747_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1471-2407-8-353","volume":"8","author":"D Zhou","year":"2008","unstructured":"Zhou D, Pan G, Zheng C, Zheng J, Yian L, Teng X. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues. BMC Cancer. 2008;8:353.","journal-title":"BMC Cancer"},{"issue":"13","key":"3747_CR9","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1158\/0008-5472.CAN-06-4128","volume":"67","author":"RM Thomas","year":"2007","unstructured":"Thomas RM, Toney K, Fenoglio-Preiser C, Revelo-Penafiel MP, Hingorani SR, Tuveson DA, Waltz SE, Lowy AM. The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression. Cancer Res. 2007;67(13):6075\u201382.","journal-title":"Cancer Res"},{"issue":"3","key":"3747_CR10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/0008-5472.CAN-09-0761","volume":"70","author":"J Logan-Collins","year":"2010","unstructured":"Logan-Collins J, Thomas RM, Yu P, Jaquish D, Mose E, French R, Stuart W, McClaine R, Aronow B, Hoffman RM, et al. Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers. Cancer Res. 2010;70(3):1130\u201340.","journal-title":"Cancer Res"},{"issue":"16","key":"3747_CR11","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1074\/jbc.M809551200","volume":"284","author":"J Wang","year":"2009","unstructured":"Wang J, Rajput A, Kan JL, Rose R, Liu XQ, Kuropatwinski K, Hauser J, Beko A, Dominquez I, Sharratt EA, et al. Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma. J Biol Chem. 2009;284(16):10912\u201322.","journal-title":"J Biol Chem"},{"issue":"52","key":"3747_CR12","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1038\/sj.onc.1207907","volume":"23","author":"X XM","year":"2004","unstructured":"XM X, Wang D, Shen Q, Chen YQ, Wang MH. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells. Oncogene. 2004;23(52):8464\u201374.","journal-title":"Oncogene"},{"issue":"2","key":"3747_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2007.08.007","volume":"257","author":"Y Lu","year":"2007","unstructured":"Lu Y, Yao HP, Wang MH. Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Cancer Lett. 2007;257(2):157\u201364.","journal-title":"Cancer Lett"},{"issue":"5","key":"3747_CR14","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1074\/jbc.M309342200","volume":"279","author":"D Angeloni","year":"2004","unstructured":"Angeloni D, Danilkovitch-Miagkova A, Miagkov A, Leonard EJ, Lerman MI. The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation. J Biol Chem. 2004;279(5):3726\u201332.","journal-title":"J Biol Chem"},{"issue":"9","key":"3747_CR15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/gcc.21968","volume":"51","author":"R Kanteti","year":"2012","unstructured":"Kanteti R, Krishnaswamy S, Catenacci D, Tan YH, EL-H E, Cervantes G, Husain AN, Tretiakova M, Vokes EE, Huet H, et al. Differential expression of RON in small and non-small cell lung cancers. Genes, chromosomes & cancer. 2012;51(9):841\u201351.","journal-title":"Genes, chromosomes & cancer"},{"issue":"8","key":"3747_CR16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/carcin\/bgq100","volume":"31","author":"HS Liu","year":"2010","unstructured":"Liu HS, Hsu PY, Lai MD, Chang HY, Ho CL, Cheng HL, Chen HT, Lin YJ, TJ W, Tzai TS, et al. An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells. Carcinogenesis. 2010;31(8):1456\u201364.","journal-title":"Carcinogenesis"},{"issue":"31","key":"3747_CR17","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1038\/sj.onc.1210238","volume":"26","author":"D Angeloni","year":"2007","unstructured":"Angeloni D, Danilkovitch-Miagkova A, Ivanova T, Braga E, Zabarovsky E, Lerman MI. Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter. Oncogene. 2007;26(31):4499\u2013512.","journal-title":"Oncogene"},{"issue":"4","key":"3747_CR18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1471-4159.2009.06027.x","volume":"109","author":"C Eckerich","year":"2009","unstructured":"Eckerich C, Schulte A, Martens T, Zapf S, Westphal M, Lamszus K. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant. J Neurochem. 2009;109(4):969\u201380.","journal-title":"J Neurochem"},{"issue":"4","key":"3747_CR19","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/ar2447","volume":"10","author":"P Jin","year":"2008","unstructured":"Jin P, Zhang J, Sumariwalla PF, Ni I, Jorgensen B, Crawford D, Phillips S, Feldmann M, Shepard HM, Paleolog EM. Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis. Arthritis Res Ther. 2008;10(4):R73.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"3747_CR20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.onc.1206075","volume":"22","author":"YQ Zhou","year":"2003","unstructured":"Zhou YQ, He C, Chen YQ, Wang D, Wang MH. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. Oncogene. 2003;22(2):186\u201397.","journal-title":"Oncogene"},{"issue":"11","key":"3747_CR21","first-page":"20778","volume":"8","author":"S Krishnaswamy","year":"2015","unstructured":"Krishnaswamy S, Mohammed AK, Amer OE, Tripathi G, Alokail MS, Al-Daghri NM. Recepteur d'Origine nantais (RON) tyrosine kinase splicing variants lacking exons 18 and 19 occur ubiquitously in lung cancer. Int J Clin Exp Med. 2015;8(11):20778\u201386.","journal-title":"Int J Clin Exp Med"},{"key":"3747_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2015.12.002","volume":"92","author":"S Krishnaswamy","year":"2016","unstructured":"Krishnaswamy S, Mohammed AK, Amer OE, Tripathi G, Alokail MS, Al-Daghri NM. Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer. Lung Cancer. 2016;92:41\u20136.","journal-title":"Lung Cancer"},{"issue":"24","key":"3747_CR23","doi-asserted-by":"crossref","first-page":"39101","DOI":"10.18632\/oncotarget.16603","volume":"8","author":"Y Ling","year":"2017","unstructured":"Ling Y, Kuang Y, Chen LL, Lao WF, Zhu YR, Wang LQ, Wang D. A novel RON splice variant lacking exon 2 activates the PI3K\/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells. Oncotarget. 2017;8(24):39101\u201316.","journal-title":"Oncotarget"},{"issue":"20","key":"3747_CR24","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.yexcr.2012.08.006","volume":"318","author":"D Wang","year":"2012","unstructured":"Wang D, Lao WF, Kuang YY, Geng SM, Mo LJ, He C. A novel variant of the RON receptor tyrosine kinase derived from colorectal carcinoma cells which lacks tyrosine phosphorylation but induces cell migration. Exp Cell Res. 2012;318(20):2548\u201358.","journal-title":"Exp Cell Res"},{"issue":"6","key":"3747_CR25","first-page":"1551","volume":"36","author":"Q Ma","year":"2010","unstructured":"Ma Q, Zhang K, Yao HP, Zhou YQ, Padhye S, Wang MH. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence. Int J Oncol. 2010;36(6):1551\u201361.","journal-title":"Int J Oncol"},{"key":"3747_CR26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1476-4598-9-307","volume":"9","author":"Q Ma","year":"2010","unstructured":"Ma Q, Zhang K, Guin S, Zhou YQ, Wang MH. Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor tyrosine kinase. Mol Cancer. 2010;9:307.","journal-title":"Mol Cancer"},{"issue":"6","key":"3747_CR27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/zeb.2014.1023","volume":"11","author":"M Witte","year":"2014","unstructured":"Witte M, Huitema LF, Nieuwenhuis EE, Brugman S. Deficiency in macrophage-stimulating protein results in spontaneous intestinal inflammation and increased susceptibility toward epithelial damage in zebrafish. Zebrafish. 2014;11(6):542\u201350.","journal-title":"Zebrafish"},{"issue":"6","key":"3747_CR28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-3083.2002.01177.x","volume":"56","author":"MH Wang","year":"2002","unstructured":"Wang MH, Zhou YQ, Chen YQ. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Scand J Immunol. 2002;56(6):545\u201353.","journal-title":"Scand J Immunol"},{"issue":"3","key":"3747_CR29","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.4049\/jimmunol.172.3.1825","volume":"172","author":"AC Morrison","year":"2004","unstructured":"Morrison AC, Wilson CB, Ray M, Correll PH. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase\/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol. 2004;172(3):1825\u201332.","journal-title":"J Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T18:22:24Z","timestamp":1570299744000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3747-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3747"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3747-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"article-number":"738"}}